Efficacy of Ruxolitinib Cream in Vitiligo by Patient Characteristics and Affected Body Areas: Descriptive Subgroup Analyses From a Phase 2, Randomized, Double-Blind Trial

Authors

Iltefat H. Hamzavi, Henry Ford HealthFollow
David Rosmarin
John E. Harris
Amit G. Pandya
Mark Lebwohl
Alice B. Gottlieb
Kathleen Butler
Fiona I. Kuo
Kang Sun
Pearl Grimes

Recommended Citation

Hamzavi I, Rosmarin D, Harris JE, Pandya AG, Lebwohl M, Gottlieb AB, Butler K, Kuo FI, Sun K, and Grimes P. Efficacy of Ruxolitinib Cream in Vitiligo by Patient Characteristics and Affected Body Areas: Descriptive Subgroup Analyses From a Phase 2, Randomized, Double-Blind Trial. J Am Acad Dermatol 2021.

Document Type

Article

Publication Date

6-2-2021

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

34089797

ePublication

ePub ahead of print